Clinical trial NCT03266458 - References

Contrast-induced Nephropathy — Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

Citation(s)

•   Amin AP, Salisbury AC, McCullough PA, Gosch K, Spertus JA, Venkitachalam L, Stolker JM, Parikh CR, Masoudi FA, Jones PG, Kosiborod M
  Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med. 2012 Feb 13;172(3):246-53. doi: 10.1001/archinternmed.2011.1202.
•   Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G
  Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.
•   Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G
  The ACEF score as predictor of acute kidney injury in patients undergoing primary percutaneous coronary intervention. Int J Cardiol. 2013 Oct 9;168(4):4386-7. doi: 10.1016/j.ijcard.2013.05.049. Epub 2013 May 24.
•   Anthopoulos, P
  , I. Antonellis, et al. (2009).
•   Barbieri L, Verdoia M, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group
  Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. Eur J Prev Cardiol. 2016 Jun;23(9):931-7. doi: 10.1177/2047487315614493. Epub 2015 Nov 2.
•   Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW
  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004 Jun 15;93(12):1515-9.
•   Bartorelli AL, Marenzi G
  Contrast-induced nephropathy. J Interv Cardiol. 2008 Feb;21(1):74-85. Epub 2007 Dec 12. Review.
•   Chen SL, Zhang J, Yei F, Zhu Z, Liu Z, Lin S, Chu J, Yan J, Zhang R, Kwan TW
  Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol. 2008 Jun 6;126(3):407-13. Epub 2007 Jul 24.
•   Cho JY, Jeong MH, Hwan Park S, Kim IS, Park KH, Sim DS, Yoon NS, Yoon HJ, Park HW, Hong YJ, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
  Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure. J Cardiol. 2010 Nov;56(3):300-6. doi: 10.1016/j.jjcc.2010.07.002. Epub 2010 Aug 13.
•   Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Wiviott SD
  Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry. Circulation. 2012 Jan 24;125(3):497-504. doi: 10.1161/CIRCULATIONAHA.111.039909. Epub 2011 Dec 16.
•   Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM
  Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001 May;37(6):1571-80.
•   Keeley EC, Boura JA, Grines CL
  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 Jan 4;361(9351):13-20. Review.
•   Keeley EC, Hillis LD
  Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med. 2007 Jan 4;356(1):47-54. Review.
•   Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC
  Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008 Feb 19;148(4):284-94. Erratum in: Ann Intern Med. 2008 Aug 5;149(3):219.
•   Kurtul A, Yarlioglues M, Duran M
  Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome. Am J Cardiol. 2017 Mar 15;119(6):819-825. doi: 10.1016/j.amjcard.2016.11.033. Epub 2016 Dec 18.
•   Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M
  A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2008 Jan 17;358(3):231-40. doi: 10.1056/NEJMoa073102.
•   Mahmoud, K
  S., Ibrahem, A. M., Saad, M., & Awny, M. (2014). Relation between serum B-type brain natriuretic peptide level and complexity & severity of coronary artery disease in non-ST elevation myocardial infarction. The Egyptian Heart Journal, 66(3), 263-268.
•   Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL
  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004 Nov 2;44(9):1780-5.
•   McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW
  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997 Nov;103(5):368-75.
•   Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G
  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9.
•   Mehran R, Brar S, Dangas G
  Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality? J Am Coll Cardiol. 2010 May 18;55(20):2210-1. doi: 10.1016/j.jacc.2009.12.051.
•   Mehta RH, Harjai KJ, Grines L, Stone GW, Boura J, Cox D, O'Neill W, Grines CL; Primary Angioplasty in Myocardial Infarction (PAMI) Investigators
  Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. J Am Coll Cardiol. 2004 May 19;43(10):1765-72.
•   Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rumsfeld JS, Gurm HS
  Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med. 2013 Sep 5;369(10):901-9. doi: 10.1056/NEJMoa1208200.
•   Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW
  Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol. 2004 Aug 4;44(3):547-53.
•   Piper WD, Malenka DJ, Ryan TJ Jr, Shubrooks SJ Jr, O'Connor GT, Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA Jr, Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath PD, O'Mears JR, Wennberg DE; Northern New England Cardiovascular Disease Study Group
  Predicting vascular complications in percutaneous coronary interventions. Am Heart J. 2003 Jun;145(6):1022-9.
•   Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD
  Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003 Dec 2;108(22):2769-75. Epub 2003 Nov 24.
•   Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G
  Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med. 1987 Jul;83(1):65-71.
•   Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW
  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 Aug;1(2):219-27.
•   Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
  Universal definition of myocardial infarction. J Am Coll Cardiol. 2007 Nov 27;50(22):2173-95.
•   Tofield A
  Pharmaco-invasive vs. facilitated percutaneous coronary intervention strategies for ST-segment-elevation acute myocardial infarction patients in the new ESC Guidelines. Eur Heart J. 2009 Dec;30(23):2817. doi: 10.1093/eurheartj/ehp409.
•   Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, Palevsky PM
  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol. 2006 Oct;17(10):2871-7. Epub 2006 Aug 23.
•   Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y
  Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677. Epub 2011 May 20.
•   Zheng ZJ, Croft JB, Giles WH, Mensah GA
  Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001 Oct 30;104(18):2158-63.

Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

Details for clinical trial NCT03266458